News Room

  • July 18, 2018
    Altasciences Participates in Clinical Trial for Type 1 Diabetes Mellitus
    Altasciences is pleased to have partnered with Xeris Pharmaceuticals, a specialty pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize ready-to-use, liquid-stable injectables, on a randomized, controlled, single blind, two-way crossover study to evaluate the efficacy and safety of their investigational glucagon injection in Type 1 diabetes mellitus (T1D) subjects in a state of insulin-induced hypoglycemia following baseline euglycemic steady-state.
  • May 23, 2018
    Altasciences Establishes Strategic Alliance with Altreos Research Partners
    Vince & Associates Clinical Research, an Altasciences company, announced today their strategic alliance with Altreos Research Partners.
  • March 7, 2018
    Third iCardiac/ERT-Certified Site for Altasciences Clinical Research
    Altasciences Clinical Research announced today that its third clinical facility, Algorithme Pharma USA, in Fargo, North Dakota, has received its iCardiac/ERT Certification.
  • January 17, 2018
    Dr. Gaetano Morelli Joins Altasciences Clinical Research’s Medical Team
    Altasciences Clinical Research, a full-service provider focused on early stage clinical research with over twenty-five years of experience, proudly announces the addition of Dr. Gaetano Morelli to the Altasciences family.
  • November 29, 2017
    Vince & Associates, an Altasciences Company, Awarded a $9.5-Million, Five-Year Contract for Clinical Pharmacology Studies
    Vince & Associates Clinical Research, an Altasciences company, announced that it has been awarded a contract to carry out clinical pharmacology studies to determine the pharmacokinetics and pharmacodynamics of new medications in humans.

Pages